SAWAI GROUP HOLDINGS Co., Ltd.
4887 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 大阪市淀川区宮原５丁目２−３０
- Website:
- https://www.sawaigroup.holdings/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
SAWAI GROUP HOLDINGS Co., Ltd. is a Japanese company dedicated to promoting healthy living. With a focus on enhancing the well-being of communities, the group engages in various health-centered initiatives, including partnerships aimed at improving health among the elderly. The company operates through subsidiaries like FrontAct, which offers innovative health monitoring solutions. Committed to sustainability and corporate governance, SAWAI GROUP HOLDINGS prioritizes environmental and social responsibilities as part of its long-term vision. Through strategic investments and a commitment to quality, the company strives to be a leader in the healthcare sector, ensuring a healthier future for all.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-27 02:47 |
Regulatory News Service
訂正発行登録書
|
Japanese | 10.0 KB | |
| 2025-06-26 07:49 |
Inside Information Statement
臨時報告書
|
Japanese | 31.2 KB | |
| 2025-06-24 08:06 |
Internal Control over Financial Reporting
内部統制報告書－第4期(2024/04/01－2025/03/31)
|
Japanese | 24.3 KB | |
| 2025-06-24 08:06 |
Regulatory News Service
確認書
|
Japanese | 9.0 KB | |
| 2025-06-24 08:05 |
Annual Report
有価証券報告書－第4期(2024/04/01－2025/03/31)
|
Japanese | 2.0 MB | |
| 2025-05-27 05:40 |
Regulatory News Service
訂正発行登録書
|
Japanese | 9.6 KB | |
| 2025-05-27 02:50 |
Inside Information Statement
臨時報告書
|
Japanese | 20.1 KB | |
| 2025-04-03 06:28 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 23.4 KB | |
| 2025-03-05 07:02 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 27.8 KB | |
| 2025-02-05 07:08 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 28.2 KB | |
| 2025-01-08 07:53 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 27.7 KB | |
| 2024-12-04 07:05 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 28.5 KB | |
| 2024-11-11 07:47 |
Regulatory News Service
確認書
|
Japanese | 9.1 KB | |
| 2024-11-11 07:46 |
Interim Report
半期報告書－第4期(2024/04/01－2025/03/31)
|
Japanese | 350.6 KB | |
| 2024-11-06 07:08 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 28.7 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
|
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
|
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
| Alma Yesodot Ltd. | Israel | KVSR | ||
|
Amphastar Pharmaceuticals Inc. | United States of America | AMPH | |
| Ananda Pharma Plc | United Kingdom | N/A | ||
|
AnGes, Inc. | Japan | 4563 |